LUCIANO POTENA

Luciano Potena graduated in Medicine in 1997 and completed his clinical fellowship in Cardiology in 2001 and earned a PhD degree in 2005 at the University of Bologna, Italy. He improved his scientific education at the Department of Experimental Cardiology of Utrecht University, The Netherlands (1999), and at the Cardiology Division of Stanford University, California (2003-05).

He currently holds the position of Director of the Heart Failure and Transplant Unit  of the IRCCS Bologna Academic Hospital.

Dr. Potena has been involved in heart transplant and advanced heart failure since his MD thesis discussion in 1997. His research path was focused on prognostic stratification of advanced heart failure, development of cardiac allograft vasculopathy, CMV infection, complications of immunosuppressive therapy after heart transplant, and antibody mediated rejection. On these topics, he co-authored over 200 full papers in peer-reviewed journals, several book chapters, and he has been involved in the design and conduction of national multicenter studies on immunosuppressive therapy, and co-authored international guidelines in the field of heart transplantation and advanced heart failure. He is participating in several EU funded research projects. He is a reviewer for several medical journals, and is currently section editor of the Journal of Heart and Lung Transplantation and associate editor of American Journal of Transplantation.

He has served as president of ESOT in 2021-23 and is now member of ESOT executive committee as Past President.